Nga đạt thỏa thuận sản xuất vaccine Sputnik V ở nhiều nước châu Âu

Ngày 15/3, Giám đốc điều hành Quỹ đầu tư trực tiếp Nga (RDIF) Kirill Dmitriev tuyên bố, quỹ này đã đạt được thỏa thuận sản xuất vaccine Sputnik V ngừa bệnh COVID-19 ở các nước châu Âu quan trọng, trong bối cảnh cơ quan y tế của Liên minh châu Âu (EU) đang thận trọng cân nhắc việc chính thức phê duyệt loại vaccine này.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh